Annexon, Inc.
Annexon, Inc. (ANNX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ANNX · as of Jun 8, 2026
Key Statistics
Explore Annexon, Inc. Data
annx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 100.0%
The ANNX analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $11.50, representing +117.39% upside from the current price of $5.29.
Competitors & Peers
annx competitorsANNX
ACIU
ALT
AURA
DBVT
DMACStock Performance
Full HistoryAbout Annexon, Inc.
Annexon, Inc. a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule …
what is annexon, inc. · annx stock overview · annexon, inc. company profile · who is annexon, inc. ceo · annx NASDAQ · annexon, inc. headquarters · annexon, inc. business segments
About Stock Overview & Key Data
Annexon, Inc. (ANNX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 24, 2020. As of the latest trading session, ANNX stock price is $5.29, with a market capitalization of $632.7M. The stock has returned +104.25% over the past 12 months and +5.38% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Annexon, Inc. stock is Buy, with an average 12-month price target of $11.50. In fiscal year 2025, Annexon, Inc. reported revenue of — and net income of -$206.7M. For detailed data — including Annexon, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Annexon, Inc. (ANNX) stock price is $5.29. The stock is traded on NASDAQ under the ticker symbol ANNX. The 52-week range is $1.85 – $7.18.